There have been 50 recent insider transactions recorded for NovoCure Limited (NVCR), including 26 buys and 21 sells. Total insider buying was valued at $9.91M and total insider selling at $2.01M.
Notable insiders with recent activity include Paravasthu Mukund, Weinberg Uri, Cordova Ashley. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NVCR
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-05 |
Paravasthu Mukund |
Chief Operating Officer |
Informative Sell |
43,246 |
$13.77 |
$595.67K |
72,832 |
| 2026-03-04 |
Weinberg Uri |
Chf Medical and Innovation Ofr |
Informative Sell |
6,412 |
$13.31 |
$85.31K |
267,190 |
| 2026-03-04 |
Cordova Ashley |
Former Chief Executive Officer |
Tax Withholding of RSU |
17,638 |
$13.30 |
$234.59K |
422,570 |
| 2026-03-04 |
Leonard Frank X |
Chief Executive Officer |
Informative Sell |
5,607 |
$13.31 |
$74.6K |
493,793 |
| 2026-03-04 |
Puri Michal Nath |
Chief Human Resources Officer |
Informative Sell |
1,100 |
$13.31 |
$14.64K |
201,322 |
| 2026-03-04 |
Leupin Nicolas |
Former Chief Medical Officer |
Informative Sell |
1,100 |
$13.31 |
$14.64K |
102,979 |
| 2026-03-04 |
Paravasthu Mukund |
Chief Operating Officer |
Informative Sell |
5,377 |
$13.31 |
$71.54K |
116,078 |
| 2026-03-04 |
Brackmann Christoph |
Chief Financial Officer |
Informative Sell |
6,412 |
$13.31 |
$85.31K |
182,842 |
| 2026-03-03 |
Doyle William F |
Executive Chairman |
RSU Award |
200,000 |
- |
- |
200,000 |
| 2026-03-03 |
Weinberg Uri |
Chf Medical and Innovation Ofr |
RSU Award |
73,340 |
$13.30 |
$975.42K |
73,340 |
| 2026-03-03 |
Leonard Frank X |
Chief Executive Officer |
RSU Award |
216,388 |
$13.30 |
$2.88M |
216,388 |
| 2026-03-03 |
Ben Arye Barak |
General Counsel |
RSU Award |
73,340 |
$13.30 |
$975.42K |
73,340 |
| 2026-03-03 |
Puri Michal Nath |
Chief Human Resources Officer |
RSU Award |
58,672 |
$13.30 |
$780.34K |
58,672 |
| 2026-03-03 |
Paravasthu Mukund |
Chief Operating Officer |
RSU Award |
7,518 |
$13.30 |
$99.99K |
7,518 |
| 2026-03-03 |
Brackmann Christoph |
Chief Financial Officer |
RSU Award |
80,674 |
$13.30 |
$1.07M |
80,674 |
| 2026-03-02 |
Weinberg Uri |
Chf Medical and Innovation Ofr |
Informative Sell |
3,272 |
$13.33 |
$43.61K |
223,477 |
| 2026-03-02 |
Cordova Ashley |
Former Chief Executive Officer |
Tax Withholding of RSU |
7,228 |
$13.67 |
$98.81K |
440,208 |
| 2026-03-02 |
Leonard Frank X |
Chief Executive Officer |
Informative Sell |
7,232 |
$13.49 |
$97.58K |
349,400 |
| 2026-02-28 |
Weinberg Uri |
Chf Medical and Innovation Ofr |
RSU Award |
12,992 |
- |
- |
226,749 |
| 2026-02-28 |
Cordova Ashley |
Former Chief Executive Officer |
RSU Award |
23,818 |
- |
- |
449,846 |
| 2026-02-28 |
Leonard Frank X |
Chief Executive Officer |
RSU Award |
18,621 |
- |
- |
356,632 |
| 2026-02-28 |
Ben Arye Barak |
General Counsel |
RSU Award |
17,755 |
- |
- |
192,328 |
| 2026-02-27 |
Weinberg Uri |
Chf Medical and Innovation Ofr |
Informative Sell |
7,461 |
$13.84 |
$103.26K |
213,757 |
| 2026-02-27 |
Cordova Ashley |
Former Chief Executive Officer |
Tax Withholding of RSU |
11,541 |
$13.75 |
$158.69K |
426,028 |
| 2026-02-27 |
Leonard Frank X |
Chief Executive Officer |
Informative Sell |
9,734 |
$13.66 |
$133K |
338,011 |
| 2026-02-27 |
Puri Michal Nath |
Chief Human Resources Officer |
Informative Sell |
1,441 |
$13.66 |
$19.69K |
162,322 |
| 2026-01-11 |
Paravasthu Mukund |
Chief Operating Officer |
Tax Withholding of RSU |
2,133 |
$14.35 |
$30.61K |
78,306 |
| 2025-12-31 |
Danziger Asaf |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-12-31 |
Ben Arye Barak |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-12-31 |
Puri Michal Nath |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-11-04 |
Paravasthu Mukund |
Chief Operating Officer |
Tax Withholding of RSU |
2,949 |
$12.23 |
$36.07K |
80,439 |
| 2025-11-04 |
Brackmann Christoph |
Chief Financial Officer |
Tax Withholding of RSU |
7,033 |
$12.23 |
$86.01K |
134,117 |
| 2025-11-01 |
Leonard Frank X |
EVP, Pres., Novocure Oncology |
Tax Withholding of RSU |
966 |
$12.81 |
$12.37K |
347,745 |
| 2025-11-01 |
Paravasthu Mukund |
Chief Operating Officer |
Tax Withholding of RSU |
168 |
$12.81 |
$2.15K |
83,388 |
| 2025-10-31 |
Puri Michal Nath |
Chief Human Resources Officer |
Tax Withholding of RSU |
752 |
$12.82 |
$9.64K |
163,762 |
| 2025-09-05 |
Cordova Ashley |
Chief Executive Officer |
Informative Buy |
81,550 |
$12.22 |
$996.86K |
437,569 |
| 2025-07-29 |
Brackmann Christoph |
Chief Financial Officer |
Informative Buy |
10,000 |
$11.63 |
$116.3K |
131,150 |
| 2025-06-30 |
Danziger Asaf |
Director |
RSU Award |
833 |
$15.13 |
$12.6K |
416,473 |
| 2025-06-30 |
Cordova Ashley |
Chief Executive Officer |
RSU Award |
833 |
$15.13 |
$12.6K |
356,019 |
| 2025-06-30 |
Leonard Frank X |
EVP, Pres., Novocure Oncology |
RSU Award |
833 |
$15.13 |
$12.6K |
348,711 |
| 2025-06-30 |
Ben Arye Barak |
General Counsel |
RSU Award |
769 |
$15.13 |
$11.63K |
174,465 |
| 2025-06-30 |
Puri Michal Nath |
Chief Human Resources Officer |
RSU Award |
833 |
$15.13 |
$12.6K |
164,514 |
| 2025-06-04 |
Hilleman Jeryl L |
Director |
RSU Award |
16,697 |
$16.72 |
$279.17K |
16,697 |
| 2025-06-04 |
Leung Gabriel |
Director |
RSU Award |
16,697 |
$16.72 |
$279.17K |
16,697 |
| 2025-06-04 |
Hung David |
Director |
RSU Award |
16,697 |
$16.72 |
$279.17K |
16,697 |
| 2025-06-04 |
Vernon W Anthony |
Director |
RSU Award |
16,697 |
$16.72 |
$279.17K |
16,697 |
| 2025-06-04 |
Scannell Timothy J |
Director |
RSU Award |
16,697 |
$16.72 |
$279.17K |
16,697 |
| 2025-06-04 |
Madden Martin J. |
Director |
RSU Award |
33,393 |
$16.72 |
$558.33K |
33,393 |
| 2025-06-04 |
Leonard Frank X |
EVP, Pres., Novocure Oncology |
RSU Award |
179,426 |
- |
- |
347,878 |
| 2025-06-04 |
Ocean Allyson J |
Director |
RSU Award |
11,215 |
- |
- |
14,269 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
